TCL Archive In Brief: Pelayo Correa Heads LSU Cancer Center; Foundation to Honor Feinstein, Mack September 5, 1997
TCL Archive Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment February 7, 2014
TCL Archive NCI Makes First NRS Award – 13 Institution Grants; 150 Individuals Pending: Lepovetsky Training Chief April 4, 1975
TCL Archive Only 20 Percent Of At-Risk Patients Are Screened For HBV Before Therapy November 25, 2011
